-+ 0.00%
-+ 0.00%
-+ 0.00%

DongKoo Bio & Pharma to Cancel 822,134 Treasury Shares

PUBT·10/28/2026 02:48:22
Listen to the news
DongKoo Bio & Pharma to Cancel 822,134 Treasury Shares
  • DongKoo Bio & Pharma resolved on October 28, 2026, to cancel 822,134 previously acquired common shares.
  • The cancellation will reduce outstanding common shares from 28,464,992 to 27,642,858 without reducing capital.
  • The shares have a book value of KRW 3 billion and a par value of KRW 500 each.
  • The treasury-share acquisition trust agreement dated July 22, 2026, was terminated on October 28, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DongKoo Bio & Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261028900158), on October 28, 2026, and is solely responsible for the information contained therein.